26489

26489
Fitzgerald J, Bleecker E, Nair P, et al. Benralizumab, an anti-interleukin-5 receptor alpha monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): A randomised, double-blind, placebo-controlled phase 3 trial. Lancet; 2016. 388(10056):2128–2141. DOI: 10.1016/S0140-6736(16)31322-8. http://www.ncbi.nlm.nih.gov/pubmed/27609406.
Einstellungen
26489
nein
Kategorisierung
Sitemap
nein
Wird geladen
zuletzt verändert: 17.12.2020 | 17:17 Uhr